カジノシークレット strengthens the Digestive System and Electrophysiology in Medical Business
—Acquires 100% of shares of River Seiko Corporation, converting it into a wholly owned subsidiary company—
カジノシークレット (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) has acquired all shares of River Seiko Corporation (Headquarters: Okaya-shi, Nagano; President: Akihiko Iguchi)*1, and will reorganize it to shift it from current business, focused on medical device contract manufacturing, to being a medical device business company with both manufacturing and R&B functions (from product development to sales planning). We will expand and strengthen digestive system business involved in interventional surgery*2, and electrophysiology business involved in diagnosis and treatment for irregular pulse.
With this conversion into a wholly owned subsidiary company, on July 1 River Seiko Corporation was renamed ワンダーカジノ Medical Tech Corporation, and it will become more closely integrated with ワンダーカジノ, improving brand value. ワンダーカジノ seeks to drastically expand business opportunities by increasing human resources and expanding functions to develop marketing, research and development, and manufacturing systems, as well as improving capability for creating new products and solutions. ワンダーカジノ aims to reach 10 billion yen in sales in these business fields by 2024.
Kaneka Medix Corporation, a wholly owned sales subsidiary company of カジノシークレット, will remain responsible for distributing Kaneka Medical Tech Corporation's products.
Furthermore, in order to contribute to health care by providing a wider range of solutions, Medical Devices Solutions Vehicle was renamed Medical Solutions Vehicle on June 1.
- 80% of the company's shares were acquired in 2013, converting it into a subsidiary company of カジノシークレット.
- Interventional surgery is a cure performed on the heart, blood vessels, brain, digestive system, or other parts of the body through the insertion of an endoscope.
<General description of ワンダーカジノ Medical Tech Corporation>
- Headquarters
- Minato-ku, Tokyo
- Description of business
- Medical device R&D and manufacturing
- President
- Akihiko Iguchi
- Shareholder
- 100% funded by カジノシークレット
High-frequency hemostat for endoscope
Electrode catheter
